Novogen is a rapidly expanding international biotechnology company based in Australia and the USA.

Novogen has three key aims:

1. To maintain its position as the world leader in the area of isoflavonoid drug technology;


2. To convert the Novogen technology platform into products that will successfully treat and prevent the major degenerative diseases of humans;


3. To establish a business model and investment opportunity that will return increasing value to shareholders.